EFFECTIVE PROBIOTICS of BLIS K12 for a healthy throat, ears and an oral cavity.

One of the most interesting news in the world of pharmaceutics, this emergence of a new effective probiotic of Blis K12. It is used at diseases of a throat, gums and upper airways. It is the first probiotic which works in an oral cavity!
Effective probiotics of Blis k12na the business, the strain of pro-biotic Streptoccocus Salivarius bacteria appeared 5 years ago, but only in August, 2015 on it published results of clinical tests and the new probiotic of BLIS K 12 got approval of the Ministry of Health of Canada and is allowed for sale in this country.

AS THERE WAS A NEW PROBIOTIC OF BLIS K12

BLIS is an abbreviation from the English term 'Bacteriocin-LikeInhibitorySubstance' — "bakteriotsino-like inhibitory substance". The founder of this probiotic, the microbiologist recognized around the world as the specialist in a probiotics of new generation and streptococci professor John Tagg from New Zealand on the basis of over 30 years of researches revealed that the same species of the bacteria inhabiting microflora of an oral cavity and the upper airways at various people have various properties. During one of researches at children of school age in Danedin, New Zealand, professor Tagg noticed regularity of the fact that useful bacteria of the sort S. salivarius at the children who do not have quinsies, otitises and others the ENT specialist diseases, considerably differ from bacteria of the same sort at the children often subject to these diseases, ability to produce natural antibiotics — the lantibiotik providing protection against pathogens. Tagg called these substances BLIS — "bakteriotsino-like inhibitory substances", thanks to their antibiotiko-like action and natural ability to suppress pathogenic microorganisms. Professor Tagg continued researches on improvement of similar pro-biotic strains for three decades. BLIS K12® strain — the top of his research career has also no analogs in the world on the spectrum of action.

Uniqueness of BLISK12® — that it produces two powerful antimicrobic substances (salivaritsin A and salivaritsin B), capable to suppress or limit growth of the undesirable bacteria leading to development of diseases of an ear, throat, nose, gums, teeth and also an unpleasant smell from a mouth.

It is the first probiotic which works in an oral cavity and allocates powerful antimicrobic molecules, counteracting a pathogenic streptococcus.

The strain of K12 was originally allocated from a mouth of the healthy child who within several years was absolutely healthy and never ached with quinsy.

Scientists found out that this concrete strain of K12 of a type of Streptoccocus Salivarius, allocates the powerful antimicrobic molecules called by BLIS (in abbreviated form): bakteriotsino-like inhibitory substances. They are capable to destroy the harmful bacteria causing quinsy, a sore throat and other upper respiratory tract infections.

Streptoccocus Salivarius is the most numerous species of the useful bacteria found in an oral cavity of healthy people. But only the small number of people can produce a special type of S. Salivarius with BLIS K12 activity.

The majority of pro-biotic bacteria in a mouth simply compete with other microorganisms? for space and food?, maintaining healthy balance of bacteria.

BLIS K12 works in a different way, it inhibits the competitors! At hit in a mouth and colonizations it at first forces out pathogenic bacteria in an amicable way, and then strikes final powerful blow, secreting 2 antimicrobic proteins of Salivaricins A and B.

Many potential pathogens are sensitive to this protein, including the bacteria causing quinsies, an unpleasant smell, infections of an ear and the upper airways.

In addition to the ability to inhibit pathogenic microorganisms, BLIS K12 interacts with certain cages in a mouth and stimulates them to increase immune protection of our systems.

Here on the picture it is shown how BLIS K12 at the moment of the high activity — works at suppression of the bacteria causing sharp pharyngitis in comparison with normal activity:


CLINICAL TESTS OF BLIS K12
Not so long ago the last clinical trials in Italy of a strain of BLIS K12 came to the end. The results published in the International magazine of Therapy of Medicine showed that the probiotic lowers repeated children's diseases of infections of an ear and throat (average otitis and tonsillitis) by 60% and 90% respectively. The second research showed the same action and on adults.

In the previous research often ill children accepted daily the pastils containing 1 trillion strain of Blis K12 within 3 months. The incidence of viral infections of a rotoglotka at the treated children was reduced by 80%, and steptokokkovy infections for 96%.

One more research at the Teykio University (Tokyo) showed that additives with BLIS K12 effectively suppress growth of the yeast causing stomatitis and oral candidiasis. The obtained data allow to use it for prevention and treatment of the candidiasis caused by reception of antibiotics or easing of immunity during cold.

Examinees who suffered from an unpleasant smell from a mouth after 3 days of rinsing with hlorgeksidiny and then uses only of pastils with BLIS K12, in a week of treatment showed considerable reduction of the black pigmented bacteria, causing this problem (the analysis of saliva by PTsR method).

Commenting on new researches, the CEO of BLIS Technologies Barry Richardson told:? We saw how BLIS K12 probiotic accepted daily very effectively gets accustomed in a mouth and a throat. It is important as BLIS develops at once several protective mechanisms which allow to protect themselves, and at the same time an oral cavity from the harmful bacteria causing tonsillitis, pharyngitis and other infections?.

The additives containing BLIS K12 probiotic reduce repetition of infections of an ear, throat and tonsillitis (quinsy) to 90%. Reduce an unpleasant smell and help at stomatitis.


EFFICIENCY OF BLIS K12
Data of clinical tests of a probiotic of BLIS K12 showed its efficiency of application at the following situations:

protection of all oral cavity, throat and gums against invasion of pathogenic organisms
increases immune protection
reduces an unpleasant smell from a mouth after a probiotic rassasyvaniye
it is used for repeated settling of an oral cavity after treatment by antibiotics
prevention and treatment of stomatitis (candidiasis)
reduces incidence of pharyngitis and tonzilitty (quinsy caused by pathogenic Streptococcus genus bacteria)
reduces repeated bacterial and viral infections of a throat and ear at children and adults (pharyngitises, quinsies, otitises)

SAFETY OF THE PROBIOTIC OF BLIS K12
The European scientists already plotted a genome of a new pro-biotic strain, having declared its full safety of application.

Tests showed that the probiotic is well transferred and does not cause any negative effects even at 10-fold excess of the recommended standard daily rate.

53 persons receiving 10 trillions units of S. salivarius K12 within 28 days took part in tests. Results of assessment of an oral cavity and a gastrointestinal state showed that the probiotic is well transferred even in high dosages.